Table 5.
Distribution of the gynecologic sample cytologic diagnoses
| Cytologic diagnosis | 2017 | 2018 |
|---|---|---|
| Unsatisfactory | 0.24 | 0.14 |
| Negative (reactive cellular change, inflammation, atrophy, etc.) | 95.10 | 95.29 |
| ASC | 3.51 | 3.64 |
| ASC-US | 3.31 | 3.45 |
| ASC-H | 0.20 | 0.19 |
| AGC | 0.05 | 0.05 |
| AGC, favor neoplastic | 0.01 | 0.01 |
| L-SIL | 0.70 | 0.65 |
| H-SIL | 0.20 | 0.19 |
| Squamous cell carcinoma | 0.02 | 0.02 |
| Adenocarcinoma | 0.00 | 0.01 |
| ASC/SIL ratio | 3.82 | 4.25 |
ASC, atypical squamous cells; ASC-US, atypical squamous cells of uncertain significance; ASC-H, atypical squamous cells, cannot exclude H-SIL; AGC, atypical glandular cells; L-SIL, low-grade squamous intraepithelial lesion; H-SIL, high-grade squamous intraepithelial lesion; ASC/SIL ratio, atypical squamous cells/squamous intraepithelial lesion ratio.